Efficacy and safety of bosentan in the treatment of persistent pulmonary hypertension of the newborn: a Metaanalysis.

Author: JiaJing-Jing, LiLing-Xue, LiMo, WeiBing, YangMing

Paper Details 
Original Abstract of the Article :
OBJECTIVES: To systematically evaluate the efficacy and safety of bosentan in the treatment of persistent pulmonary hypertension of the newborn (PPHN). METHODS: Chinese Journal Full-text Database, Weipu Database, Wanfang Data, China Biology Medicine disc, PubMed, Web of Science, Embase, and Cochran...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8974651/

データ提供:米国国立医学図書館(NLM)

Bosentan: A New Approach for Persistent Pulmonary Hypertension

Persistent pulmonary hypertension of the newborn (PPHN), like a treacherous desert canyon, can be life-threatening for infants. This study examines the efficacy and safety of bosentan, a medication used to manage PPHN, through a comprehensive meta-analysis of clinical trials. The study analyzes the combined data from multiple studies, similar to mapping a vast desert landscape, to assess the effectiveness of bosentan in reducing treatment failure rates. The study found that bosentan was effective in treating PPHN, but also highlighted the importance of monitoring potential side effects, like identifying potential hazards in a desert environment.

A New Path to Treatment

The meta-analysis provides compelling evidence that bosentan can significantly improve outcomes for infants with PPHN, offering a promising treatment option in the desert of newborn health challenges. It's like finding a safe passage through a dangerous canyon, leading to improved health and well-being. The study emphasizes the importance of careful monitoring for potential side effects, like being vigilant for dangers while navigating a desert landscape.

Navigating the Desert of Newborn Health: A Focus on Safety

The study highlights the importance of vigilant monitoring for potential side effects when using bosentan. It's a reminder that even in the quest for effective treatments, safety is paramount. This is like carefully surveying the desert terrain for potential hazards before embarking on a journey. Close collaboration between healthcare providers and families is essential for ensuring the best possible outcomes for infants with PPHN, creating a safe and supportive environment for navigating this challenging health journey.

Dr. Camel's Conclusion

This meta-analysis provides valuable insights into the use of bosentan for PPHN. It's a reminder that even in the most challenging deserts of newborn health, we have the tools and knowledge to provide effective and safe care for our youngest patients.

Date :
  1. Date Completed 2022-03-31
  2. Date Revised 2023-09-16
Further Info :

Pubmed ID

35351265

DOI: Digital Object Identifier

PMC8974651

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.